価格表

在庫・価格 : 2024年04月23日 19時00分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IFN-γ, Human, ELISpot Kit
データシート※最新のデータシートでない場合があります
EL285 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥80,000
(未発注)
追加

在庫・価格 : 2024年04月23日 19時00分 現在

IFN-γ, Human, ELISpot Kit

  • 商品コード:EL285
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥80,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Klencke B et al. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. Clin. Cancer Res. 2002 May;8(5):1028-37
Klencke B et al
2002/01/01
Sample Type: Whole Cells PubMed
2 Bailey T et al. A multidonor ELISPOT study of IL-1 beta, IL-2, IL-4, IL-6, IL-13, IFN-gamma and TNF-alpha release by cryopreserved human peripheral blood mononuclear cells. J. Immunol. Methods 2002 Dec;270(2):171-82
Bailey T et al
2002/01/01
Sample Type: Whole Cells PubMed
3 Ethuin F et al. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab. Invest. 2004 Oct;84(10):1363-71
Ethuin F et al
2004/01/01
Sample Type: Whole Cells PubMed
4 Correale J et al. Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta. J. Neuroimmunol. 2005 May;162(1-2):173-83
Correale J et al
2005/01/01
Sample Type: Whole Cells PubMed
5 Ohshita A et al. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients. Int. J. Oncol. 2006 May;28(5):1163-71
Ohshita A et al
2006/01/01
Sample Type: Whole Cells PubMed
6 Deniz G et al. Regulatory NK cells suppress antigen-specific T cell responses. J. Immunol. 2008 Jan;180(2):850-7
Deniz G et al
2008/01/01
Species: Human, Sample type: Whole Cells PubMed
7 Hirosako S et al. Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells. Clin. Exp. Immunol. 2009 Feb;155(2):266-74
Hirosako S et al
2009/01/01
Sample Type: Whole Cells PubMed
8 Ysrraelit MC et al. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008 Dec;71(24):1948-54
Ysrraelit MC et al
2008/01/01
Sample Type: Whole Cells PubMed
9 Bellone S et al. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer. Cancer 2009 Feb;11
Bellone S et al
2009/01/01
Sample Type: Whole Cells PubMed
10 Ovsyannikova IG et al. Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine 2009 May;27(25-26):3359-66
Ovsyannikova IG et al
2009/01/01
Sample Type: Whole Cells PubMed
11 Longo O et al. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine 2009 May;27(25-26):3306-12
Longo O et al
2009/01/01
Sample Type: Whole Cells PubMed
12 Ge W et al. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells. Leuk. Res. 2009 Jul;33(7):948-57
Ge W et al
2009/01/01
Sample Type: Whole Cells PubMed
13 McAulay KA et al. Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease. J. Immunol. 2009 Mar;182(6):3892-901
McAulay KA et al
2009/01/01
Sample Type: Whole Cells PubMed
14 Derfuss T et al. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc. Natl. Acad. Sci. U.S.A. 2009 May;106(20):8302-7
Derfuss T et al
2009/01/01
Sample Type: Whole Cells PubMed
15 Fan K et al. Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate/interleukin-2 and mediates its antitumor activity in vivo. J. Interferon Cytokine Res. 2009 Aug;29(8):451-60
Fan K et al
2009/01/01
Sample Type: Whole Cells PubMed
16 Correale J et al. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J. Immunol. 2009 Nov;183(9):5999-6012
Correale J et al
2009/01/01
Sample Type: Whole Cells PubMed
17 Kundu S et al. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J. Immunol. 2010 Jun;184(11):6529-36
Kundu S et al
2010/01/01
Sample Type: Whole Cells PubMed
18 Poirier N et al. Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates. Clin. Exp. Immunol. 2011 May;164(2):265-74
Poirier N et al
2011/01/01
Sample Type: Whole Cells PubMed
19 Umlauf BJ et al. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Viral Immunol. 2011 Oct;24(5):415-20
Umlauf BJ et al
2011/01/01
Sample Type: whole cells PubMed
20 Nogueira RS et al. Antigen-triggered interferon-γ and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease. Clin. Exp. Immunol. 2014 Sep;177(3):679-86
Nogueira RS et al
2014/01/01
Sample Type: Whole Cells PubMed
21 Hagen J et al. Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays. Cells 2015;4(1):84-95
Hagen J et al
2015/01/01
Sample Type: whole cells PubMed
22 Zhao J et al. Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis. Int J Mol Sci 2017 Jun;18(7)
Zhao J et al
2017/01/01
Species: Human PubMed
23 Yang W et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat. Med. 2019 05;25(5):767-775
Yang W et al
2019/01/01
PubMed
24 Pang YB et al. A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cells Int 2019;2019:5680327
Pang YB et al
2019/01/01
PubMed
25 Ren J et al. Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition. Clin. Cancer Res. 2017 May;23(9):2255-2266
Ren J et al
2017/01/01
PubMed
26 Peng S et al. Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood. Cell Rep 2019 09;28(10):2728-2738.e7
Peng S et al
2019/01/01
PubMed
27 Mohseni AH et al. The First Clinical Use of a Recombinant <i>Lactococcus lactis</i> Expressing Human Papillomavirus Type 16 E7 Oncogene Oral Vaccine: A Phase I Safety and Immunogenicity Trial in Healthy Women Volunteers. Mol Cancer Ther 2020 02;19(2):717-
Mohseni AH et al
2020/01/01
PubMed
28 Taghinezhad-S S et al. Phase 1 Safety and Immunogenicity Trial of Recombinant <i>Lactococcus lactis</i> Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine. Mol Ther Methods Clin Dev 2019 Dec;15:40-51
Taghinezhad-S S et al
2019/01/01
PubMed
29 Wang X et al. Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis. Microb Pathog 2020 Jan;142:104009
Wang X et al
2020/01/01
PubMed
30 Mysore V et al. Fc&#x3B3;R engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity. Nat Commun 2021 08;12(1):4791
Mysore V et al
2021/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Klencke B et al. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. Clin. Cancer Res. 2002 May;8(5):1028-37
    Klencke B et al
    2002/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Bailey T et al. A multidonor ELISPOT study of IL-1 beta, IL-2, IL-4, IL-6, IL-13, IFN-gamma and TNF-alpha release by cryopreserved human peripheral blood mononuclear cells. J. Immunol. Methods 2002 Dec;270(2):171-82
    Bailey T et al
    2002/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ethuin F et al. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab. Invest. 2004 Oct;84(10):1363-71
    Ethuin F et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Correale J et al. Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta. J. Neuroimmunol. 2005 May;162(1-2):173-83
    Correale J et al
    2005/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ohshita A et al. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients. Int. J. Oncol. 2006 May;28(5):1163-71
    Ohshita A et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Deniz G et al. Regulatory NK cells suppress antigen-specific T cell responses. J. Immunol. 2008 Jan;180(2):850-7
    Deniz G et al
    2008/01/01
  • 備考:
    Species: Human, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Hirosako S et al. Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells. Clin. Exp. Immunol. 2009 Feb;155(2):266-74
    Hirosako S et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Ysrraelit MC et al. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008 Dec;71(24):1948-54
    Ysrraelit MC et al
    2008/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Bellone S et al. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer. Cancer 2009 Feb;11
    Bellone S et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Ovsyannikova IG et al. Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine 2009 May;27(25-26):3359-66
    Ovsyannikova IG et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Longo O et al. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine 2009 May;27(25-26):3306-12
    Longo O et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ge W et al. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells. Leuk. Res. 2009 Jul;33(7):948-57
    Ge W et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    McAulay KA et al. Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease. J. Immunol. 2009 Mar;182(6):3892-901
    McAulay KA et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Derfuss T et al. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc. Natl. Acad. Sci. U.S.A. 2009 May;106(20):8302-7
    Derfuss T et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Fan K et al. Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate/interleukin-2 and mediates its antitumor activity in vivo. J. Interferon Cytokine Res. 2009 Aug;29(8):451-60
    Fan K et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Correale J et al. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J. Immunol. 2009 Nov;183(9):5999-6012
    Correale J et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Kundu S et al. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J. Immunol. 2010 Jun;184(11):6529-36
    Kundu S et al
    2010/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Poirier N et al. Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates. Clin. Exp. Immunol. 2011 May;164(2):265-74
    Poirier N et al
    2011/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Umlauf BJ et al. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Viral Immunol. 2011 Oct;24(5):415-20
    Umlauf BJ et al
    2011/01/01
  • 備考:
    Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Nogueira RS et al. Antigen-triggered interferon-&#x3B3; and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease. Clin. Exp. Immunol. 2014 Sep;177(3):679-86
    Nogueira RS et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Hagen J et al. Comparative Multi-Donor Study of IFN&#x3B3; Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays. Cells 2015;4(1):84-95
    Hagen J et al
    2015/01/01
  • 備考:
    Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Zhao J et al. Secretion of IFN-&#x3B3; Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis. Int J Mol Sci 2017 Jun;18(7)
    Zhao J et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Yang W et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat. Med. 2019 05;25(5):767-775
    Yang W et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Pang YB et al. A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cells Int 2019;2019:5680327
    Pang YB et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Ren J et al. Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition. Clin. Cancer Res. 2017 May;23(9):2255-2266
    Ren J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Peng S et al. Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood. Cell Rep 2019 09;28(10):2728-2738.e7
    Peng S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Mohseni AH et al. The First Clinical Use of a Recombinant <i>Lactococcus lactis</i> Expressing Human Papillomavirus Type 16 E7 Oncogene Oral Vaccine: A Phase I Safety and Immunogenicity Trial in Healthy Women Volunteers. Mol Cancer Ther 2020 02;19(2):717-
    Mohseni AH et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Taghinezhad-S S et al. Phase 1 Safety and Immunogenicity Trial of Recombinant <i>Lactococcus lactis</i> Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine. Mol Ther Methods Clin Dev 2019 Dec;15:40-51
    Taghinezhad-S S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Wang X et al. Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis. Microb Pathog 2020 Jan;142:104009
    Wang X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Mysore V et al. Fc&#x3B3;R engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity. Nat Commun 2021 08;12(1):4791
    Mysore V et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed